– BLA based on data from the global Phase 1/2 CADENZA trial NORTH CHICAGO, Ill., Sept. 30, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced submission of a new Biologics License Application ...

Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced clearance by the U.S. Food and Drug Administration (FDA) of ...

Students continue to pursue postsecondary education—particularly Latino and Black students—and a growing share of those applicants are choosing to submit SAT and ACT scores even when institutions are ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Gradient, an API platform for AI developers, announced today it has raised $10 million in seed funding led by Wing VC, with participation from Mango Capital and ...

SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced clearance by the U.S. Food and ...

In the rapidly evolving landscape of modern manufacturing and engineering, a new technology is emerging as a crucial enabler-Data-Model Fusion (DMF). A recent review paper published in Engineering ...

Mg isotope compositions of some typical geological standard samples measured by the DS method and the SSB method in different laboratories. The sample-standard-bracketing (SSB) method and double-spike ...

This study introduced an efficient method for solving non-linear equations. Our approach enhances the traditional spectral conjugate gradient parameter, resulting in significant improvements in the ...